相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study
Alfredo Berruti et al.
BMC CANCER (2014)
An expression signature of the angiogenic response in gastrointestinal neuroendocrine tumours: correlation with tumour phenotype and survival outcomes
D. J. Pinato et al.
BRITISH JOURNAL OF CANCER (2014)
Phase I study of sorafenib in combination with everolimus (RAD001) in patients with advanced neuroendocrine tumors
Jennifer A. Chan et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Sorafenib and bevacizumab combination targeted therapy in advanced neuroendocrine tumour: A phase II study of Spanish Neuroendocrine Tumour Group (GETNE0801)
Daniel Castellano et al.
EUROPEAN JOURNAL OF CANCER (2013)
Sorafenib versus capecitabine in the management of advanced hepatocellular carcinoma
Omar Abdel-Rahman et al.
MEDICAL ONCOLOGY (2013)
Combination treatment with metronomic temozolomide, bevacizumab and long-acting octreotide for malignant neuroendocrine tumours
Anna Koumarianou et al.
ENDOCRINE-RELATED CANCER (2012)
Prospective Study of Bevacizumab Plus Temozolomide in Patients With Advanced Neuroendocrine Tumors
Jennifer A. Chan et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms
Guenter Kloeppel
ENDOCRINE-RELATED CANCER (2011)
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
Marianne E. Pavel et al.
LANCET (2011)
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors.
Eric Raymond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Everolimus for Advanced Pancreatic Neuroendocrine Tumors.
James C. Yao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The pathological diagnosis of neuroendocrine tumors: common questions and tentative answers
Marco Volante et al.
VIRCHOWS ARCHIV (2011)
Angiogenic markers endoglin and vascular endothelial growth factor in gastroenteropancreatic neuroendocrine tumors
Patricia Kuiper et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Phase II Clinical Trial of Sorafenib in Metastatic Medullary Thyroid Cancer
Elaine T. Lam et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte Oncology Network
Maria P. Brizzi et al.
BMC CANCER (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
Anja Rinke et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Targeting vascular endothelial growth factor in advanced carcinoid tumor: A random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alfa-2b
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors
Irvin M. Modlin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Gastroenteropancreatic neuroendocrine tumours
Irvin M. Modlin et al.
LANCET ONCOLOGY (2008)
Phase II study of thalidomide in patients with metastatic carcinoid and islet cell tumors
Kimberly A. Varker et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors
MH Kulke et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours
JK Ramage et al.
GUT (2005)
Circulating levels of angiogenic cytokines can predict tumour progression and prognosis in neuroendocrine carcinomas
ME Pavel et al.
CLINICAL ENDOCRINOLOGY (2005)
Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours - A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS)
U Plockinger et al.
NEUROENDOCRINOLOGY (2004)
Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms) -: Part I -: General overview
K Öberg et al.
ACTA ONCOLOGICA (2004)
Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms) -: Part II -: Specific NE tumour types
K Öberg et al.
ACTA ONCOLOGICA (2004)
分享论文
